FTC Keeps Franchise Disclosure Forms for Another Three Years
Published Date: 8/18/2026
Notice
Summary
The Federal Trade Commission wants to keep its Franchise Rule paperwork rules for three more years, helping people get clear info before buying a franchise. This affects franchisors who must keep detailed records and share important facts with potential buyers. Comments on this plan are open until September 17, 2026, with no new costs expected.
Analyzed Economic Effects
4 provisions identified: 0 benefits, 4 costs, 0 mixed.
Franchisors Must Give Franchise Disclosure
If you sell franchises, you must give every prospective purchaser a Franchise Disclosure Document (FDD) that describes the franchisor, its business, the proposed franchise, and any statements about financial performance. The Rule requires this disclosure so prospective buyers can compare franchise offerings.
Written Basis Required for Financial Claims
If a franchisor makes any financial performance representation about sales, income, or profits, the franchisor must have written information that provides a reasonable basis for that representation. This means franchisors must document support for any earnings claims they make to prospects.
Estimated Annual Burden and Cost to Businesses
The FTC estimates the Rule imposes 22,480 annual burden hours on private-sector businesses, with estimated annual labor costs of $8,403,680 and estimated annual non-labor costs of $4,800,000. The FTC is seeking OMB approval to extend the existing Paperwork Reduction Act clearance for three years.
Three-Year FDD Record Preservation Requirement
Franchisors must preserve materially different copies of their Franchise Disclosure Documents (FDDs) for 3 years. The Rule also requires franchisors to maintain records to help enforcement of the Rule.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-22581, Petition for Rulemaking of New Hope Now
New Hope Now wants the Federal Trade Commission to create rules that require companies to clearly label where nonhuman flesh products and byproducts come from. This affects businesses selling these products and helps consumers know exactly what they're buying. People have until December 7, 2026, to share their thoughts, and any changes could impact labeling costs and transparency.
2026-21798, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission wants to keep its Fuel Rating Rule going for three more years, which helps gas sellers and makers share clear info about fuel quality. This affects fuel refiners, importers, distributors, and retailers who spend time and money keeping records and sharing fuel ratings. If you have thoughts, you’ve got until November 25, 2026, to speak up!
2026-21659, Publicis and LiveRamp; Analysis of Proposed Agreement Containing Consent Order To Aid Public Comment
The FTC is reviewing a deal between Publicis and LiveRamp that might have broken competition rules. They’ve proposed a consent order to fix the issues and want the public’s thoughts by November 23, 2026. This affects both companies and aims to keep the market fair without any immediate money changes announced.
2026-21630, Granting of Requests for Early Termination of the Waiting Period under the Premerger Notification Rules
If you're planning a big business deal, you usually have to wait before making it official so the government can check it out. But sometimes, the wait gets cut short! This document lists deals that got the green light early in September 2026, meaning those businesses can move faster without extra delays or extra costs.
2026-21510, Petition for Rulemaking of Jason Plotzker
Jason Plotzker asked the Federal Trade Commission to create rules that stop penny auction and pay-per-bid auction companies from using tricky or misleading price ads. This affects anyone who shops or sells through these auctions, aiming to make pricing clearer and fairer. People have until November 20, 2026, to share their thoughts, and no money changes hands yet—this is just the start of the conversation.
2026-20971, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission wants to keep collecting info about how companies use 'negative option' plans—where you’re signed up unless you say no—for three more years. They’re asking the public to share thoughts by December 14, 2026. This affects businesses using these plans and helps protect consumers without adding new costs.
Previous / Next Documents
Previous: 2026-16826, Tribal Consultation Meeting
Pursuant to the Head Start Act, notice is hereby given of one Tribal Consultation session to be held between HHS/ACF OHS leadership and the leadership of Tribal governments operating Head Start and Early Head Start programs. The purpose of this consultation session is to discuss ways to better meet the needs of American Indian and Alaska Native (AIAN) children and their families, taking into consideration funding allocations, distribution formulas, and other issues affecting the delivery of Head Start services in their geographic locations.
Next: 2026-16829, Testosterone Use in Menopausal Women; Public Workshop; Request for Comments
The Food and Drug Administration's (FDA) Office of Women's Health and the Center for Drug Evaluation and Research are announcing a public workshop titled "Testosterone Use in Menopausal Women." The purpose of the public workshop is to examine the current scientific evidence and critical knowledge gaps related to testosterone use in menopausal women to help inform future research and potential drug development of testosterone products for menopausal women. Researchers, educators, industry, clinicians, patients, and consumers may benefit from attending this scientific workshop. Presentations will examine the physiological roles of testosterone throughout a woman's life, including age-related decline, the menopausal transition, challenges associated with measuring and interpreting testosterone blood levels, and how these levels correlate with clinical symptoms and conditions. Speakers will review current and potential clinical uses of testosterone in menopausal women and examine the strengths and limitations of available data supporting those uses. Speakers will discuss regulatory considerations, including the development of robust efficacy and safety data, to support a marketing application for testosterone in menopausal women for the treatment of various clinical conditions, and study design considerations for evaluating long-term safety outcomes in women.